Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04945148
Title Oxidative Phosphorylation Targeting In Malignant Glioma Using Metformin Plus Radiotherapy Temozolomide (OPTIMUM)
Acronym OPTIMUM
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hopital Foch
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | FRA

Additional content available in CKB BOOST